Publisher: Adis International
ISSN: 1173-8324
Source: Inpharma, Vol.1, Iss.1545, 2006-01, pp. : 15-16
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Docetaxel: impressive survival results in NSCLC
Inpharma, Vol. 1, Iss. 1244, 2000-01 ,pp. :
Docetaxel regimen improves survival in early breast cancer
Inpharma, Vol. 1, Iss. 1475, 2005-01 ,pp. :
Docetaxel: Onycholysis: case report
Reactions Weekly, Vol. 1, Iss. 1215, 2008-01 ,pp. :
Docetaxel: Extravasation: case report
Reactions Weekly, Vol. 1, Iss. 1010, 2004-01 ,pp. :
Erlotinib dominates docetaxel for NSCLC
Inpharma, Vol. 1, Iss. 1612, 2007-01 ,pp. :